Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats
about
Type IV collagen is transcriptionally regulated by Smad1 under advanced glycation end product (AGE) stimulation.Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic miceEndothelial dysfunction in diabetes.Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.Therapeutic relevance of ozone therapy in degenerative diseases: Focus on diabetes and spinal pain.Clinical applications of arterial stiffness: therapeutics and pharmacology.Aminoguanidine prevents age-related aortic stiffening in Fisher 344 rats: aortic impedance analysis.An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness.Medical treatment of diabetic retinopathy.Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats.Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophyAminoguanidine prevents fructose-induced deterioration in left ventricular-arterial coupling in Wistar rats.Effects of olmesartan on arterial stiffness in rats with chronic renal failure.Breakers of advanced glycation end products restore large artery properties in experimental diabetes.Inhibition of advanced glycation endproduct formation by acetaldehyde: role in the cardioprotective effect of ethanol.Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagenCurrent therapeutic interventions in the glycation pathway: evidence from clinical studies.Advanced glycation end products: role in pathology of diabetic cardiomyopathy.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Novel therapeutic targets in the management of atrial fibrillation.Advanced glycation end-products and atherosclerosis.Oxidative stress and lipids in diabetes: a role in endothelium vasodilator dysfunction?Mechanical properties of the common carotid artery in Williams syndrome.Pharmacological prevention of cardiovascular aging--targeting the Maillard reactionAldosterone receptor inhibition alters the viscoelastic biomechanical behavior of the aortic wall.Nitric oxide-mediated corpus cavernosal smooth muscle relaxation is impaired in ageing and diabetes.Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies
P2860
Q31036740-6D5FDBC9-E6A5-4B7E-83D7-677F5A58CF86Q31146191-0B463C22-C8F9-46A2-8D62-9DFE00522479Q33959485-080FB2A3-CB9A-4BE6-A8E5-77345379ED27Q34055011-B17E1EFF-48FA-42C4-B183-38BD8C9E64C9Q34557662-848D7C9A-BFF4-458C-A831-FF17EDF3548FQ34647819-29EAC6E2-DEA6-421C-B895-8B5C2A4647F1Q35045662-7C670342-6491-48C0-84E6-7114849D373CQ35081898-DAD56D96-EB6B-43BD-B1E6-2B453B0E997DQ35175679-DF83F0CF-BFA2-4A56-B4C3-309F0F586479Q35566544-6420634A-7661-48EF-AD65-5AC280A7AF5CQ35805813-7AAC7C5D-FC92-4B37-9DE7-9705F4481953Q36052796-173E1F7E-3F86-4DB7-B369-66DF294757A1Q36320297-1B0081FB-7EC0-4A17-9F95-86F48E251A19Q36477705-D33BFF39-813E-4130-A7C3-81F44501E85EQ37184929-994F8192-2DFC-49B2-89C2-51FB194E0FFBQ37364608-E4DC1947-1953-4AAE-A0BD-2E69FD287108Q37395276-288B18EE-531F-40FF-A90F-72376679CA73Q38070906-1CA4E9FE-4AC2-499D-807E-152D051BDC7DQ38081119-41DED6A6-BFB8-4452-8284-CC25D6D0321BQ38096444-8BC7EF2B-70C7-4B7C-A367-0953FFB690E9Q38236746-5B7CE081-8233-4341-9D77-7D76031B3853Q41250355-2263C975-9C4F-4052-B975-6A90A5A52617Q41740391-75C9264E-BFA7-43EA-9A90-2CBE430A9700Q41869648-80EBE2DC-5FAD-4CF1-AF1D-93E4DD4E496EQ42126940-9BFD1E78-0E4E-4465-A159-18D754430B75Q43093139-A88F94AA-200B-4DEC-9EB8-29EA1E25515CQ43543926-2E805456-7499-488E-8348-12F05C74334FQ58577346-44AF86B8-5CD1-4A94-AFA2-726DDDFC8B7A
P2860
Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats
description
1993 nî lūn-bûn
@nan
1993 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Aminoguanidine treatment incre ...... ge arteries from diabetic rats
@ast
Aminoguanidine treatment incre ...... ge arteries from diabetic rats
@en
type
label
Aminoguanidine treatment incre ...... ge arteries from diabetic rats
@ast
Aminoguanidine treatment incre ...... ge arteries from diabetic rats
@en
prefLabel
Aminoguanidine treatment incre ...... ge arteries from diabetic rats
@ast
Aminoguanidine treatment incre ...... ge arteries from diabetic rats
@en
P2093
P2860
P356
P1476
Aminoguanidine treatment incre ...... ge arteries from diabetic rats
@en
P2093
Boudier HA
Huijberts MS
Kruseman AC
Poitevin P
Wolffenbuttel BH
P2860
P304
P356
10.1172/JCI116716
P407
P577
1993-09-01T00:00:00Z